当前位置:首页 >英文主页 >中英对照 > 报告详情

CHAI:2025年艾滋病(HIV)市场报告:低收入和中等收入国家艾滋病毒市场现状(英文版)(56页).pdf

上传人: 1****1 编号:981115 2025-12-03 56页 9.40MB

下载:

1、The state of HIV treatment,testing,and prevention in low-and middle-income countriesISSUE 16,NOVEMBER 20252025HIV MARKETREPORTDISCLAIMER The data sources primarily used for analysis in the report include Clinton Health Access Initiative(CHAI)country teams,Ministry of Health counterparts,stakeholder

2、resources and conversations(e.g.Global Fund,PEPFAR,UNAIDS,Unitaid,WHO,and civil society partners),and published research.CHAI has taken precautions to verify the information shared in the report.However,the analysis in the report is not exhaustive,and the responsibility for the interpretation and us

3、e of the material lies with the reader.The mention of specific companies or products does not imply CHAIs endorsement or recommendation.ACKNOWLEDGMENT This report was made possible through the generous support of Unitaid,with complementary support from the UK Foreign,Commonwealth&Development Office

4、and the Gates Foundation.CONTACT Carolyn Amole Vice President,HIV,Hepatitis,and TB camoleclintonhealthaccess.orgCover images,clockwise from the top:A lab technician at a clinic in Nigeria;a child attends a clinic in Tanzania;a healthcare worker takes stock at a hospital in Lao PDR22025 CHAI HIV Mark

5、et ReportACRONYMS 4EXECUTIVE SUMMARY 6FOREIGN AID CUTS 11HIV PREVENTION 14HIV TESTING 20PEDIATRIC HIV 26ADULT TREATMENT 34ADVANCED HIV DISEASE(AHD)39TREATMENT MONITORING 47APPENDIX A:FORECASTED API DEMAND IN GA LMICS 51APPENDIX B:CHAI ARV BENCHMARK PRICE COMPARISON LIST 53APPENDIX C:NOTES ON METHODO

6、LOGY 54APPENDIX D:REFERENCES 55CONTENTSHIV Market Report32025 CHAI HIV Market ReportTable of Contents3HPThree months of weekly rifapentine and isoniazid3TCLamivudine5FCFlucytosineABCAbacavirAGYWAdolescent girls and young womenAHDAdvanced HIV diseaseAIDSAcquired immunodeficiency syndromeANCAntenatal

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据《2025年HIV市场报告》,以下为全文主要内容关键点: 1. 外援削减导致HIV治疗、检测和预防服务受到严重影响,特别是对儿童的影响更为严重。 2. 2025年上半年,HIV检测数量下降8%,新诊断病例下降22%,未治疗的儿童数量增加。 3. 成人HIV治疗开始人数减少5%,未接受治疗的人数增加10%。 4. PrEP开始人数减少37%,预计将导致更多HIV感染。 5. 长效PrEP药物lenacapavir的引入为HIV预防带来变革性机遇,但需要更多投资以支持其大规模推广。 6. 需要关注儿童HIV诊断和治疗、儿童药物供应安全、国家数据稳定性和多利益相关方参与等问题。
"HIV检测下降,疫情反弹风险高?" "儿童HIV治疗中断,未来何去何从?" "LEN新药上市,预防艾滋病新希望?"
客服
商务合作
小程序
服务号
折叠